Cited by 45Neuroinflammation and Neurodegeneration MechanismsPeroxisome Proliferator-Activated ReceptorsInflammatory mediators and NSAID effects

15‐Deoxy‐Δ12,14‐prostaglandin J2regulates the functional state and the survival of microglial cells through multiple molecular mechanisms

Bernardo, Antonietta, Ajmone‐Cat, Maria Antonietta, Levi, Giulio, Minghetti, Luisa·2003·Journal of Neurochemistry

Abstract

We have previously reported that rat primary microglial cultures express the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and that several functions associated with the activation of these cells, including nitric oxide (NO) and tumor necrosis factor-alpha synthesis, are down-regulated by 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone, two specific PPAR-gamma agonists. Here we demonstrate that microglial cells not only express a functionally active PPAR-gamma, but also synthesize large amounts of 15d-PGJ2 upon stimulation with lipopolysaccharide (LPS). In addition, we show that, although 15d-PGJ2 and ciglitazone were equally effective in reducing microglial activation when used at 1-5 microm concentrations, 15d-PGJ2, but not of ciglitazone, reduced PGE2 production at low concentration (0.1 microm) and induced a time-dependent microglial impairment and apoptosis at high concentration (10 microm). Interestingly, the inhibition of PGE2 production was achieved mainly through the inhibition of cycloxygenase-2 enzymatic activity, as the expression of this enzyme and that of the microsomal isoform of PGE synthase remained unaltered. These findings suggest that 15d-PGJ2 affects the functional state and the survival of activated microglia through mechanisms only in part dependent on PPAR-gamma and that the concentration of 15d-PGJ2 is crucial in determining the particular microglial function affected.

Integrity signals

Registry

Crossref · 10.1046/j.1471-4159.2003.02045.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BV-2 microglial cells lack PPARγ expression.

    “As previously stated, BV-2 microglial cells have been reported to have an absence of PPARγ expression [48,49], yet a drastic reduction in LD accumulation was observed following rosiglitazone supplementation.”

The citation lists haven’t been fetched yet

References 56 · Cited by 45

Authors
Bernardo, A., Ajmone‐Cat, M. A., Levi, G., & Minghetti, L.
Affiliations
Istituto Superiore di Sanità (IT)
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2003-09-26
Volume
87
Issue
3
Pages
742-751
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1509973252
Cited by
45
References
56
Citations by year
2024: 3 · 2021: 2 · 2020: 1 · 2019: 1 · 2016: 2 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 2
FWCI
3.18
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
Keywords
15-deoxy-Δ12,14-prostaglandin J2, microglial activation, microglial survival, apoptosis, PPARγ, ciglitazone, prostaglandin E2, cyclooxygenase-2, lipopolysaccharide, nitric oxide, TNF-α, concentration-dependent effects
MeSH terms
Animals, Cell Survival, Cells, Cultured, Dose-Response Relationship, Drug, Isoenzymes, Lipopolysaccharides, Nitric Oxide, Prostaglandin-Endoperoxide Synthases, Transcription Factors, Prostaglandin D2, Dinoprostone, Signal Transduction, Apoptosis, Microglia, Receptors, Cytoplasmic and Nuclear, Thiazolidinediones, Rats, Cyclooxygenase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review